ASSAY FOR ASSESSMENT OF ENDOSOMAL TRANSPORT Russian patent published in 2018 - IPC G01N33/50 

Abstract RU 2673086 C2

FIELD: microbiology.

SUBSTANCE: invention relates to a method for assessing the ability of an endosome to release a test molecule, said test molecule being a clostridial neurotoxin or a redirected non-cytotoxic protease and being capable of proteolytic cleavage and inactivation of the SNARE protein, wherein the method comprises: I) contacting the eukaryotic cell with the test molecule, which is to be assessed for endosome release ability, wherein said eukaryotic cell comprises a cell membrane comprising a binding site present on the outer surface of the cell membrane of said cell; II) incubating the test molecule with said eukaryotic cell, which thus allows: a) the test molecule to bind to and form a bound complex with the binding site present on the eukaryotic cell, thereby allowing said bound complex to enter the eukaryotic cell by endocytosis; b) one or more endosomes to form in said cell, wherein one or more endosomes comprise the test molecule; and c) said test molecule to enter the cytosol of the eukaryotic cell through the endosomal membrane of one or more endosomes; III) removing an excess test molecule that is not bound to binding sites present on the eukaryotic cells; IV) detecting the amount of test molecules present in one or more endosomes, or detecting the number of test molecules present in the cytosol of said eukaryotic cell; V) comparing the number of test molecules detected in step IV), with a control value, wherein said control value indicates the number of test molecules present in one or more endosomes or the number of test molecules present in the cytosol prior to performing step IV); VI) calculating the endosome release parameter for the test molecule by determining the relative change in the number of test molecules that are present in one or more endosomes, or by determining the relative change in the amount of test molecules present in the cytosol of said eukaryotic cell; wherein step (IV) comprises detecting a test molecule using a fluorescent label. Also, the invention relates to a method for assessing the ability of a test molecule of an inhibitor to inhibit endosomal release of a control molecule with one or more eukaryotic cell endosomes.

EFFECT: assay for assessment of endosomal transport is proposed.

9 cl, 12 ex, 8 dwg

Similar patents RU2673086C2

Title Year Author Number
THERAPEUTIC FUSION PROTEINS 2012
  • Cheddok Dzhon
  • Kharper Elejn
RU2651492C2
SORTASE-LABELED CLOSTRIDIA NEUROTOXINS 2020
  • Loss, Omar
  • Elliott, Mark
RU2801120C2
FUSION PROTEINS AND METHODS OF TREATMENT, PREVENTION OR ALLEVIATION OF PAIN 2013
  • Dzhejms Piter
  • Foster Kejt
  • Cheddok Dzhon
  • Aoki Rodzher Kej
  • Styuard Lens
  • Frensis Dzhozef
RU2652954C2
IMMUNOCONJUGATES FOR THE SPECIFIC INDUCTION OF T CELL CYTOTOXICITY AGAINST TARGET CELLS 2016
  • Dzyadek Sebastian
  • Lifke Aleksander
  • Lifke Valeriya
  • Khillringkhaus Lars
RU2746021C2
COMPOSITIONS AND METHODS FOR TOXIGENIC TESTING 2012
  • Dzhonson Erik Artur
  • Pellett Sabin
  • Uajtmarsh Regina Kler Mejer
  • Tepp Uillyam Govard
RU2616281C2
METHODS OF INCREASING SPECIFIC PINCH OF BOTULINUM NEUROTOXIN BY CELLS 2016
  • Yatske Klaudiya
  • Ejzele Karl-Khajnts
  • Mander Gerd
  • Fink Klaus
RU2684404C2
SYSTEM FOR STABLE EXPRESSION OF TUMOR-ASSOCIATED ANTIGENS BASED ON LENTIVIRAL VECTOR 2018
  • Frolova Elena Ivanovna
  • Chumakov Stepan Petrovich
  • Kravchenko Yuliya Evgenevna
RU2725493C2
USE OF HSP70 AS ENZYME ACTIVITY REGULATOR 2009
  • Jensen Tomas Kirkegor
  • Jotella Mar'Ja Khelena
RU2571946C2
METHOD OF INTRODUCTION OF PNA MOLECULE CONJUGATED WITH POSITIVE PEPTIDE, IN CYTOSOL AND/OR NUCLEUS BY PHOTOCHEMICAL INTERNALISATION (PCI) 2005
  • Khevig Ehjvinn
  • Fodstad Ejstejn
  • Beeh Sigurd
RU2435859C2
AGENTS AND METHODS FOR DETERMINING BIOLOGICAL ACTIVITY OF NEUROTOXIN POLYPEPTIDES IN CELLS 2014
  • Bryunn Korneliya
RU2704808C2

RU 2 673 086 C2

Authors

Kharper Elejn

Dates

2018-11-22Published

2013-10-23Filed